Comparison of the Surgical Lung Histopathologic Features of Patients with Pulmonary Disease Due to Mycobacterium Avium Complex Versus Mycobacterium Abscessus Complex

2019 ◽  
Author(s):  
E.D. Chan ◽  
K.J. Potts ◽  
C. Cool ◽  
M. Althoff ◽  
S.D. Groshong ◽  
...  
Keyword(s):  
Pulmonary Disease ◽  
Mycobacterium Avium ◽  
Mycobacterium Avium Complex ◽  
Mycobacterium Abscessus ◽  
Complex Versus ◽  
Mycobacterium Abscessus Complex ◽  
Histopathologic Features

scholarly journals FULMINANT RESPIRATORY FAILURE IN MULTI-DRUG RESISTANT MYCOBACTERIUM ABSCESSUS COMPLEX WITH MYCOBACTERIUM AVIUM COMPLEX CO-INFECTION

CHEST Journal ◽  
2020 ◽  
Vol 158 (4) ◽  
pp. A459-A460
Author(s):  
Divya Mounisha Thimmareddygari ◽  
Susanne Ajao ◽  
Rutwik Patel ◽  
Richard Miller ◽  
Jihad Slim
Keyword(s):  
Respiratory Failure ◽  
Mycobacterium Avium ◽  
Mycobacterium Avium Complex ◽  
Mycobacterium Abscessus ◽  
Drug Resistant ◽  
Mycobacterium Abscessus Complex

Nontuberculous Mycobacteria

2021 ◽  
Vol 42 (04) ◽  
pp. 567-586
Author(s):  
Shera Tan ◽  
Shannon Kasperbauer
Keyword(s):  
Risk Factor ◽  
Pulmonary Disease ◽  
Mycobacterium Avium ◽  
Mycobacterium Avium Complex ◽  
Nontuberculous Mycobacteria ◽  
Mycobacterium Abscessus ◽  
Pulmonary Infections ◽  
Human Pathogens ◽  
Common Manifestation

AbstractNontuberculous mycobacteria (NTM) are ubiquitous in the environment and 193 species of NTM have been discovered thus far. NTM species vary in virulence from benign environmental organisms to difficult-to-treat human pathogens. Pulmonary infections remain the most common manifestation of NTM disease in humans and bronchiectasis continues to be a major risk factor for NTM pulmonary disease (NTM PD). This article will provide a useful introduction and framework for clinicians involved in the management of bronchiectasis and NTM. It includes an overview of the epidemiology, pathogenesis, diagnosis, and management of NTM PD. We will address the challenges faced in the diagnosis of NTM PD and the importance of subspeciation in guiding treatment and follow-up, especially in Mycobacterium abscessus infections. The treatment of both Mycobacterium avium complex and M. abscessus, the two most common NTM species known to cause disease, will be discussed in detail. Elements of the recent ATS/ERS/ESCMID/IDSA NTM guidelines published in 2020 will also be reviewed.

The Expanding Spectrum of Mycobacterium avium Complex-Associated Pulmonary Disease

CHEST Journal ◽  
2006 ◽  
Vol 130 (4) ◽  
pp. 1234-1241 ◽  
Author(s):  
E. Andrew Waller ◽  
Archana Roy ◽  
Lisa Brumble ◽  
Andras Khoor ◽  
Margaret M. Johnson ◽  
...  
Keyword(s):  
Pulmonary Disease ◽  
Mycobacterium Avium ◽  
Mycobacterium Avium Complex

hsa-miR-346 is a potential serum biomarker of Mycobacterium avium complex pulmonary disease activity

2017 ◽  
Vol 23 (10) ◽  
pp. 703-708 ◽  
Author(s):  
Tomoyasu Nishimura ◽  
Eiko Tamizu ◽  
Shunsuke Uno ◽  
Yoshifumi Uwamino ◽  
Hiroshi Fujiwara ◽  
...  
Keyword(s):  
Disease Activity ◽  
Pulmonary Disease ◽  
Mycobacterium Avium ◽  
Mycobacterium Avium Complex ◽  
Serum Biomarker

Treatment of Mycobacterium avium Complex (MAC) Pulmonary Disease

2004 ◽  
Vol 57 (3) ◽  
pp. 234 ◽  
Author(s):  
Won Jung Koh ◽  
O Jung Kwon ◽  
Eun Hae Kang ◽  
Gee Young Suh ◽  
Man Pyo Chung ◽  
...  
Keyword(s):  
Pulmonary Disease ◽  
Mycobacterium Avium ◽  
Mycobacterium Avium Complex
Sign in / Sign up

Export Citation Format

Share Document